Saltar al contenido
Merck

Craviten hydrolysis in plasma in vitro.

Polish journal of pharmacology and pharmacy (1981-10-01)
E Pogonowska-Wala
RESUMEN

Craviten hydrolysis in vitro was studied in human, rat and canine plasma and erythrocytes. Craviten was degraded during the incubation with plasma and the hydrolysis was inhibited by trimethoxybenzoic acid, a metabolite of Craviten. Erythrocyte enzymes do not participate in the hydrolysis.

MATERIALES
Referencia del producto
Marca
Descripción del producto

Sigma-Aldrich
3,4,5-Trimethoxybenzoic acid, ReagentPlus®, 99%